Custom Carbohydrate Synthesis
Overview

Advanced chemical and enzymatic methods have enabled the synthesis of various saccharides. CD BioGlyco has developed highly integrated approaches that can combine chemical and enzymatic methods to quickly compose saccharide-related products. We can complete small (mg) and large (g) quantities of saccharides and transfer the technology to a bulk manufacturing plant. All our final products will be thoroughly analyzed by our advanced technologies such as mass spectrometry and high field NMR to ensure quality.
Our team of professionals, most with a Ph.D. degree, is highly skilled in the areas of carbohydrate, nucleosidation, glycosylation, high purity complex products, and synthetic route development. We are proficient in the design and customization of complex multi-step reaction schemes and provide customers with customized overall solutions in the fields of biopharmaceuticals, therapy, and diagnosis to develop saccharides and saccharide-related molecules.
Key Technologies
Enzymatic synthesis; Chemical synthesis
Precision-Crafted Sugars, Scientifically Defined
We leverage a comprehensive array of established and innovative techniques to ensure the successful and efficient construction of even the most challenging carbohydrate structures. Our core technologies include both enzymatic and chemical synthesis approaches. Enzymatic synthesis offers unparalleled stereo- and regioselectivity, mimicking natural biosynthetic pathways to create complex glycans with high fidelity.
Workflow

Case Study: High-Precision Custom Synthesis of Complex Carbohydrate Derivatives
- Background
Carbohydrate derivatives are invaluable tools in glycobiology, medicinal chemistry, and drug discovery. However, their synthesis presents notorious challenges due to multiple hydroxyl groups requiring precise stereochemical and regioselective manipulation. A client approached CD BioGlyco, requiring a structurally diverse library of custom carbohydrate derivatives. The request demanded the parallel synthesis of core parent molecules and their respective chemically modified counterparts to support their downstream biological evaluations.
- The Challenge
The project required the design, synthesis, and strict quality control of 22 target carbohydrate derivative compounds in parallel. The structural diversity consisted of two main series:
- 11 Core Parent Compounds: Featuring variations in functional groups attached to the carbohydrate ring (including primary amides, secondary amides with methyl, ethyl, and propyl chains, as well as distinct bulky branched alkyl chains like tert-butyl, sec-butyl, and isobutyl groups).
- 11 Acetylated Derivatives: The completely acetylated forms corresponding to each core parent molecule, demanding absolute conversion and high purity.
The primary hurdle lay in achieving high purity across varying scales (ranging from 2 mg to over 50 mg) while dealing with structurally delicate functional groups and differing physical properties.
- Our Solution & Synthesis Strategy
Leveraging our advanced carbohydrate chemistry platform, our technical team established a robust protocol to execute the custom organic synthesis. Our expert chemists successfully completed the multi-step synthesis for all 22 target compounds:
- Functional Group Fine-Tuning: Precise control over nitrogen- and carbon-linked substitutions on the glycone backbone, navigating from unalkylated amides up to long-branched alkyl side chains.
- Regioselective Acetylation: Designed optimal esterification pathways to smoothly convert the core molecules into their corresponding fully acetylated target derivatives without affecting neighboring functional groups or risking epimerization.
- Results & Quality Control Specifications
All 22 target compounds were successfully delivered, meeting or exceeding the structural validation and purity requirements specified by the client. Every single batch underwent rigorous analytical screening using state-of-the-art liquid chromatography-mass spectrometry (LC-MS) and high-resolution proton nuclear magnetic resonance spectroscopy (1H NMR).
| Compound_ID | molecular weight | Amount_(mg) | Purity | Form |
|---|---|---|---|---|
| Target 1 | xxx | 2.67 | 99.0% | White solid |
| Target 2 | xxx | 27.80 | 98.0% | White solid |
| Target 3 | xxx | 16.54 | 98.0% | White solid |
| Target 4 | xxx | 41.36 | 99.0% | White solid |
| Target 5 | xxx | 6.51 | 97.0% | White solid |
| ... | ... | ... | ... | ... |
Fig.1 LC-MS spectrum of Target 1. (CD BioGlyco)
Fig.2 1H NMR spectrum of Target 1 (DMSO). (CD BioGlyco)
Fig.3 1H NMR spectrum of Target 1 (DMSO-D2O). (CD BioGlyco)
- Client Project Management & Experience
At CD BioGlyco, we value scientific transparency and reliable execution:
- Seamless Onboarding: The client was paired with a senior project manager who designed a customized synthetic protocol aligned precisely with their target structural requirements.
- Active Communication: Regular progress reports were delivered to keep the client updated on intermediate steps and quality control milestones.
- IP Protection: Full intellectual property rights and raw analytical files were safely transferred to the client upon project completion under strict confidentiality terms.
Publication Data
DOI.: 10.3390/catal10101142
Technology: Solvent-free reaction
Journal: Catalysts
IF: 3.8
Published: 2020
Results: This comprehensive review explores solvent-free methodologies in carbohydrate synthetic chemistry, emphasizing the pivotal role of catalysis in enhancing reactivity and selectivity. The authors analyze a wide range of solvent-free techniques, including mechanochemical ball milling, melt reactions, and catalytic solid-state processes, for key transformations such as protecting group manipulations (acylations, acetalations, benzylations), glycosylations, glycoconjugations, and biomass depolymerization. Crucially, the review highlights how catalysts (e.g., Lewis acids like In(OTf)3, Yb(OTf)3; solid acids; enzymes; organotin reagents) enable precise control over regioselectivity and stereoselectivity in these solvent-free environments, often offering advantages like simplified procedures, improved yields, or unique selectivity profiles compared to traditional solvent-based methods. The work underscores the growing potential of solvent-free, catalytically driven approaches as sustainable and efficient strategies for constructing complex carbohydrates and valorizing biomass-derived sugars.
Applications
- Generating fluorescently or radio-labeled glycans to track metabolism, localization, and interactions within cells and organisms.
- Creating affinity tags (e.g., biotinylated glycans) for isolating and characterizing glycan-binding proteins.
- Developing activity-based probes (ABPs) for studying enzyme activity in complex biological samples.
Advantages of Us
- Expertise in both enzymatic synthesis (for natural fidelity) and advanced chemical synthesis (for diverse scaffolds) provides unmatched flexibility.
- Enzymatic synthesis utilizing glycosyltransferases/glycosidases ensures unparalleled stereo- and regioselectivity, enabling complex structures.
- The integrated approach combining synthesis and advanced analytics guarantees stringent quality control, optimizing yield, purity, and structural integrity.
Frequently Asked Questions
Associated Services
The synthesis laboratory at CD BioGlyco uses the most advanced synthesis technology to provide customers with the customized synthesis of oligosaccharides, polysaccharides, sugar-nucleotides, and carbohydrate antigens. Our mission is to help academic laboratories and industries explore the biological and pharmaceutical effects of saccharides. If you have any further queries, please contact us directly for more detailed information.
Reference
- Traboni, S.; et al. Solvent-free approaches in carbohydrate synthetic chemistry: role of catalysis in reactivity and selectivity. Catalysts. 2020, 10(10): 1142. (Open Access)
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform













